Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

IDEAYA Biosciences Announced That It Has Entered Into An Option And License Agreement For A Potential First-in-class B7H3/PTK7 BsADC Program With Biocytogen Pharmaceuticals (Beijing) Co.

Author: Benzinga Newsdesk | July 31, 2024 06:04am

Posted In: IDYA